Susquehanna International Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Susquehanna International Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-33,200	Closed	-$524K	–	13290
2024 Q4	$524K	Buy	33,200 +4,200	+14%	+$63.1K	﹤0.01%	8548
2024 Q3	$461K	Buy	29,000 +6,000	+26%	+$96.5K	﹤0.01%	8654
2024 Q2	$350K	Buy	23,000 +1,000	+5%	+$14.3K	﹤0.01%	9114
2024 Q1	$323K	Buy	+22,000	New	+$321K	﹤0.01%	9549
2023 Q4	–	Sell	-53,500	Closed	-$716K	–	13145
2023 Q3	$716K	Buy	+53,500	New	+$724K	﹤0.01%	7393
2021 Q4	–	Sell	-18,500	Closed	-$241K	–	13764
2021 Q3	$241K	Sell	18,500 -74,000	-80%	-$986K	﹤0.01%	11091
2021 Q2	$1.36M	Buy	+92,500	New	+$1.29M	﹤0.01%	6920
2021 Q1	–	Sell	-25,500	Closed	-$364K	–	12747
2020 Q4	$364K	Sell	25,500 -21,000	-45%	-$283K	﹤0.01%	8904
2020 Q3	$647K	Buy	46,500 +2,000	+4%	+$23.8K	﹤0.01%	7126
2020 Q2	$472K	Sell	44,500 -15,000	-25%	-$153K	﹤0.01%	7480
2020 Q1	$480K	Buy	59,500 +31,500	+113%	+$263K	﹤0.01%	7029
2019 Q4	$227K	Sell	28,000 -24,000	-46%	-$190K	﹤0.01%	8537
2019 Q3	$394K	Buy	+52,000	New	+$387K	﹤0.01%	7769
2019 Q2	–	Sell	-42,500	Closed	-$344K	–	10727
2019 Q1	$344K	Sell	42,500 -30,500	-42%	-$232K	﹤0.01%	6984
2018 Q4	$550K	Sell	73,000 -18,000	-20%	-$127K	﹤0.01%	5840
2018 Q3	$630K	Buy	91,000 +35,000	+63%	+$234K	﹤0.01%	6111
2018 Q2	$361K	Buy	+56,000	New	+$353K	﹤0.01%	7476
2017 Q3	–	Sell	-65,000	Closed	-$548K	–	9484
2017 Q2	$548K	Buy	65,000 +8,000	+14%	+$65K	﹤0.01%	6477
2017 Q1	$458K	Buy	+57,000	New	+$492K	﹤0.01%	6645
2014 Q2	–	Sell	-87,500	Closed	-$768K	–	10038
2014 Q1	$768K	Buy	+87,500	New	+$761K	﹤0.01%	5989

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Susquehanna International Group's RDY Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Dr. Reddy's Laboratories (RDY) in Q1 2026: 42,300 shares worth $586K. The stake represents ﹤0.01% of the portfolio and ranks #9250 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in RDY as recently as Q1 2024.

Susquehanna International Group first reported a position in RDY in Q2 2013 and has held it in 20 quarters since. The position peaked at $2.79M in Q4 2015. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Susquehanna International Group held 42,300 shares of Dr. Reddy's Laboratories worth $586K as of Q1 2026.
Dr. Reddy's Laboratories was a new Susquehanna International Group position in Q1 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9250 holding.
Susquehanna International Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 20 quarters since.
Susquehanna International Group's Dr. Reddy's Laboratories position peaked at $2.79M in Q4 2015.
248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.